NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE
Post# of 341
Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM) is planning to participate in the 2022 Virtual Growth Conference. The conference is slated for March 28–30, 2022, from 9 a.m. to 5 p.m. ET. Cybin CEO Doug Drysdale will present at the premier event, which is presented by Maxim Group LLC and hosted by M-Vest. Drysdale’s presentation will be available on demand at 9 a.m. ET on Monday, March 28. An archived version of Drysdale’s webcast will be available on the Company’s investor relations website.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer